Gm haplotypes in inflammatory demyelinating polyneuropathies.
作者信息
Feeney D J, Pollard J D, McLeod J G, Stewart G J, De Lange G G
机构信息
Department of Medicine, University of Sydney, NSW, Australia.
出版信息
Ann Neurol. 1989 Dec;26(6):790-2. doi: 10.1002/ana.410260619.
PMID:2557797
Abstract
The possible association of Gm haplotypes with inflammatory neuropathies has been studied in 59 patients with Guillain-Barré syndrome and 55 patients with chronic inflammatory demyelinating polyradiculoneuropathy. The frequency of Gm haplotype 1,2,17;21 (or z,a,x;g) was significantly raised in the patients with Guillain-Barré syndrome. These findings provide further evidence for an association of chromosome 14 genes with inflammatory neuropathies.
摘要
相似文献
1
Gm haplotypes in inflammatory demyelinating polyneuropathies.
Ann Neurol. 1989 Dec;26(6):790-2. doi: 10.1002/ana.410260619.
2
Immunization and risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy.
Muscle Nerve. 1996 Sep;19(9):1230-1.
3
Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis.
Ann Neurol. 1991 Jul;30(1):48-53. doi: 10.1002/ana.410300110.
4
Anti-GD1a ganglioside antibodies in peripheral motor syndromes.
Ann Neurol. 1996 Apr;39(4):539-43. doi: 10.1002/ana.410390417.
5
Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: pathogenesis and treatment.
Semin Neurol. 1994 Jun;14(2):123-30. doi: 10.1055/s-2008-1041069.
6
Elevated serum levels of endothelial leukocyte adhesion molecules in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Ann Neurol. 1994 May;35(5):621-4. doi: 10.1002/ana.410350518.
7
[Inflammatory and immunologically-induced diseases of the peripheral nerves].
Internist (Berl). 1984 Oct;25(10):599-606.
8
[Clinical factors relating to the presence of serum anti-GM1 and GD1b antibodies in demyelinating neuropathy--study using a multivariate analysis].
Rinsho Shinkeigaku. 1994 May;34(5):454-60.
9
High-dose intravenous immunoglobulin therapy in dysimmune neuropathies.
Neurol Sci. 2002 Apr;23 Suppl 1:S25-32. doi: 10.1007/s100720200012.
10
[Antiganglioside antibodies: when, which and for what].
Neurologia. 2001 Aug-Sep;16(7):293-7.
Zotero 插件